Recent data indicates that retatrutide, a novel medication, may represent a major step in weight loss . This drug combines the effects of a GLP-1 agonist and a GIP agonist , potentially offering a enhanced benefit than existing approaches . Patient research have demonstrated promising results , including substantial declines in weight and improveme